Guarino et al. proposed that changes in sympathetic and parasympathetic nerve activity, selective leptin resistance, low ghrelin levels, and hyperinsulinemia are possible mechanisms underlying sympathetic activation in obesity [19]. The gene discussed is GHRL; the disease is Hyperinsulinemia.